Change of coagulation system after cardiac implantable electronic device implantatio
Not Applicable
Completed
- Conditions
- arrhythmia, heart failure
- Registration Number
- JPRN-UMIN000009645
- Lead Sponsor
- Disease Control and Homeostasis, Kanazawa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) Needs to continue anticoagulation therapy 2) Judged inappropriated patients by Doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link cardiac implantable electronic devices to coagulation system changes in arrhythmia and heart failure patients?
How does cardiac implantable electronic device implantation compare to standard-of-care treatments in modulating coagulation parameters for arrhythmia and heart failure?
Which biomarkers are associated with coagulation system alterations following cardiac implantable electronic device implantation in patients with arrhythmia and heart failure?
What are the potential adverse events related to coagulation system changes after cardiac implantable electronic device implantation and their management strategies?
Are there any related compounds or combination therapies that influence coagulation pathways in the context of cardiac implantable electronic device use for arrhythmia and heart failure?